MedPath

Clinical Study of 18F-FAPI-RGD in Interstitial Lung Disease Associated With Connective Tissue Disease

Recruiting
Conditions
Interstitial Lung Disease
Registration Number
NCT06143540
Lead Sponsor
Sichuan Provincial People's Hospital
Brief Summary

The goal of this observational study is to examine clinical utility of 18F-FAPI-RGD PET/CT imaging in evaluating connective tissue disease-associated interstitial lung disease. Participants will undergo clinical evaluation and 18F-FAPI-RGD PET/CT examination.

Detailed Description

Interstitial lung disease is an overarching term for a wide range of disorders characterized by inflammation and/ or fibrosis in the lungs. Interstitial lung disease associated connective tissue diseases(CTD-ILD) is one of the most common types.The goal of this study is to explore the feasibility of using 18F-FAPI-RGD, a dual-targeting heterodimeric PET tracer that recognizes both fibroblast activation protein (FAP) and integrin αvβ3 for detecting connective tissue disease associated interstitial lung disease (CTD-ILD), and analyze the relationship between 18F- FAPI-RGD PET/CT images and related parameters of lung function, clinical laboratory indicators and HRCT scores.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Age 18 and above
  • Patients who have been diagnosed with, or are clinically highly suspected of ILD
  • Patients who have been diagnosed with, or are clinically highly suspected of CTD-ILD
Exclusion Criteria
  • Pregnant or breastfeeding
  • Patients with tumor, other respiratory diseases, and lung surgery
  • Abnormal cardiopulmonary function or mental state, unable tolerate PET/CT

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Correlation between clinical indicators and PET/CT results2 months

Correlation of clinical pulmonary function indexes, HRCT, laboratory examination indexes and 18F-FAPI-RGD PET/CT results

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sichuan Provincial People's Hospital

🇨🇳

Chengdu, Sichuan, China

© Copyright 2025. All Rights Reserved by MedPath